Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.00 from other evidence | 0.00 |
| cell type Human Protein Atlas | not detected in single-cell data | 0.00 |
| chemistry Open Targets | compounds already reach it: rontalizumab, sifalimumab | 0.81 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | no papers tie it to Parkinson's yet | 1.00 |
| pathways Reactome | 6 pathways; mostly immune signalling | 0.90 |
No case: the score is under the bar. Receipt 12678
Sealed predictions
- IFNA17 in dopamine neurons, braakn/a → n/areceipt 12684
Swarm cases
receipt 12684: IFNA17 in dopamine neurons, braak
- cell type
- IFNA17 is not measured in dopamine neurons; looking elsewhere.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for IFNA17 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts